Adma Biologics (ADMA)

$8.65 +0.19 (2.25%)
Market Cap 1.96B
Revenue (ttm) 510.17M
Net Income (ttm) 146.93M
EPS (ttm) N/A
PE Ratio 12.39
Forward PE 10.79
Profit Margin 28.80%
Debt to Equity Ratio 0.50
Volume 931,375
Avg Vol 3,178,566
Day's Range N/A - N/A
Shares Out 231.77M
Stochastic %K 42%
Beta 0.73
Analysts Sell
Price Target $15.60

Company Profile

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the tre...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 478 5552
Fax: 201 478 5553
Address:
465 State Route 17, Ramsey, United States
justusfied
justusfied Aug. 3 at 4:24 PM
$ADMA after the Culper crap, I stopped watching this stock and just acknowledged I’ll be holding large bags for quite some time. My timeline was. $30 by 2030. Has anything fundamentally changed that makes that number look unattainable now?
0 · Reply
USMAgrad
USMAgrad Aug. 3 at 3:14 PM
$ADMA Nice lil bounce back after that $8.50-ish dip!
0 · Reply
apc62657
apc62657 Aug. 2 at 1:43 PM
$ADMA Mckesson revenue should kick in strongly this quarter. That coupled with normalization of Bivigam would make for a strong quarter
1 · Reply
StockBraker
StockBraker Aug. 1 at 1:40 PM
$ADMA Wednesday - 4:05PM EST - I'm going to either be drinking or drinking.
2 · Reply
buylocellhi
buylocellhi Jul. 30 at 5:54 PM
$ADMA there is only 1 golden rule to trading with the computers and actually gives the trader a chance at being successful but looking at the board, I don’t think anybody has figured it out yet… au revoir
0 · Reply
StockBraker
StockBraker Jul. 30 at 2:51 PM
$ADMA Adding more.
0 · Reply
tilance
tilance Jul. 30 at 2:38 PM
$ADMA opened a position here today.,.
0 · Reply
Patastic
Patastic Jul. 30 at 12:57 PM
$ADMA Welp. Days are getting shorter. I’m back in Baby! Time to fly. Let’s go!
0 · Reply
StockBraker
StockBraker Jul. 29 at 8:25 PM
$ADMA https://ir.admabiologics.com/news-releases/news-release-details/adma-biologics-report-second-quarter-2026-financial-results
0 · Reply
Merlintrader
Merlintrader Jul. 29 at 4:47 PM
$ADMA ADMA Biologics (Nasdaq: $ADMA): The Full Updated Deep Dive Into ASCENIV, Q1 2026, IVIG Market Pressure, Margin Expansion and the Revenue-Quality Test https://www.merlintrader.com/adma-biologics-stock-hub/
0 · Reply
Latest News on ADMA
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

Jul 31, 2026, 1:20 PM EDT - 3 days ago

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in ADMA BIOLOGICS, INC. Lawsuit - ADMA

Jul 30, 2026, 10:07 AM EDT - 4 days ago

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in ADMA BIOLOGICS, INC. Lawsuit - ADMA

ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026

Jul 29, 2026, 7:00 AM EDT - 5 days ago

ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026

Did You Lose Money Investing in ADMA Biologics, Inc. (ADMA)? Contact Robbins LLP for Information About Recovering Your Losses

Jul 27, 2026, 10:00 AM EDT - 7 days ago

Did You Lose Money Investing in ADMA Biologics, Inc. (ADMA)? Contact Robbins LLP for Information About Recovering Your Losses

$ADMA Fraud Notification: ADMA Biologics Sued for Fraud Over Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law

Jul 24, 2026, 6:34 AM EDT - 10 days ago

$ADMA Fraud Notification: ADMA Biologics Sued for Fraud Over Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law

Adma Biologics price target lowered to $17 from $20 at Mizuho

2026-07-15T11:25:44.000Z - 19 days ago

Adma Biologics price target lowered to $17 from $20 at Mizuho

$ADMA Fraud Notification: ADMA Biologics Sued for Securities Fraud After Channel Stuffing Claims Spark a 29% Stock Drop – Investors Notified to Contact BFA Law by August 10

Jul 6, 2026, 6:48 AM EDT - 4 weeks ago

$ADMA Fraud Notification: ADMA Biologics Sued for Securities Fraud After Channel Stuffing Claims Spark a 29% Stock Drop – Investors Notified to Contact BFA Law by August 10

ADMA INVESTOR REMINDER: ADMA Biologics, Inc. Investors Have Until August 10, 2026 To Seek Lead Plaintiff Role

Jul 2, 2026, 7:00 PM EDT - 4 weeks ago

ADMA INVESTOR REMINDER: ADMA Biologics, Inc. Investors Have Until August 10, 2026 To Seek Lead Plaintiff Role

ADMA BIOLOGICS, INC. (ADMA) INVESTOR ALERT Investors With Large Losses in ADMA Biologics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jun 24, 2026, 9:24 AM EDT - 5 weeks ago

ADMA BIOLOGICS, INC. (ADMA) INVESTOR ALERT Investors With Large Losses in ADMA Biologics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Grabar Law Office Investigates ADMA Biologics, Inc. (ADMA) on Behalf of Long-Term Shareholders

Jun 23, 2026, 7:55 AM EDT - 5 weeks ago

Grabar Law Office Investigates ADMA Biologics, Inc. (ADMA) on Behalf of Long-Term Shareholders

20 growth stocks priced as value stocks

Jun 15, 2026, 10:53 AM EDT - 7 weeks ago

20 growth stocks priced as value stocks

AMG ANIP ARR BILL CG DAN EFC

$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop – Investors Notified to Contact BFA Law

Jun 11, 2026, 1:33 PM EDT - 7 weeks ago

$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop – Investors Notified to Contact BFA Law

Adma Biologics resumed with an Outperform at Raymond James

2026-06-10T11:40:39.000Z - 7 weeks ago

Adma Biologics resumed with an Outperform at Raymond James

ADMA Biologics Investigation: ADMA Biologics (ADMA) Investigated for Alleged Channel Stuffing – Contact BFA Law if You Suffered Losses

Jun 10, 2026, 6:41 AM EDT - 7 weeks ago

ADMA Biologics Investigation: ADMA Biologics (ADMA) Investigated for Alleged Channel Stuffing – Contact BFA Law if You Suffered Losses

ADMA Legal Claims: ADMA Biologics may have Misrepresented its Revenue Sources to Investors – Contact BFA Law about its Pending Securities Fraud Investigation

Jun 3, 2026, 6:07 AM EDT - 2 months ago

ADMA Legal Claims: ADMA Biologics may have Misrepresented its Revenue Sources to Investors – Contact BFA Law about its Pending Securities Fraud Investigation

ADMA Biologics Transcript: AGM 2026

Jun 2, 2026, 10:00 AM EDT - 2 months ago

ADMA Biologics Transcript: AGM 2026

$ADMA Securities News: ADMA Biologics Investigated for Securities Fraud Over Channel Stuffing Allegations – Investors with Losses Notified to Contact BFA Law

May 29, 2026, 6:33 AM EDT - 2 months ago

$ADMA Securities News: ADMA Biologics Investigated for Securities Fraud Over Channel Stuffing Allegations – Investors with Losses Notified to Contact BFA Law

$ADMA Shareholder Announcement: ADMA Biologics may have Misled Investors about its Revenue – Contact BFA Law about its Pending Investigation

May 25, 2026, 7:18 AM EDT - 2 months ago

$ADMA Shareholder Announcement: ADMA Biologics may have Misled Investors about its Revenue – Contact BFA Law about its Pending Investigation

ADMA Inquiry News: ADMA Biologics Investors are Notified of BFA Law's Ongoing Investigation into the Company's Potential Misstatements – Contact the Firm if You Lost Money

May 22, 2026, 6:43 AM EDT - 2 months ago

ADMA Inquiry News: ADMA Biologics Investors are Notified of BFA Law's Ongoing Investigation into the Company's Potential Misstatements – Contact the Firm if You Lost Money

ADMA Securities Investigation: ADMA Biologics 29% Stock Drop Triggers Securities Fraud Investigation Over Channel Stuffing Claims – Investors Urged to Contact BFA Law

May 20, 2026, 6:20 AM EDT - 2 months ago

ADMA Securities Investigation: ADMA Biologics 29% Stock Drop Triggers Securities Fraud Investigation Over Channel Stuffing Claims – Investors Urged to Contact BFA Law

ADMA Fraud Notice: ADMA Biologics is being Investigated for Securities Fraud after 29% Stock Drop -- Investors Reminded to Contact BFA Law

May 18, 2026, 6:07 AM EDT - 2 months ago

ADMA Fraud Notice: ADMA Biologics is being Investigated for Securities Fraud after 29% Stock Drop -- Investors Reminded to Contact BFA Law

ADMA Shareholder News: ADMA Biologics Investigated for Securities Fraud Over Alleged Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law

May 15, 2026, 6:33 AM EDT - 2 months ago

ADMA Shareholder News: ADMA Biologics Investigated for Securities Fraud Over Alleged Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law

$ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money

May 11, 2026, 6:15 AM EDT - 3 months ago

$ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money

$ADMA Investor News: ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered Losses

May 8, 2026, 6:07 AM EDT - 3 months ago

$ADMA Investor News: ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered Losses

Adma Biologics price target lowered to $20 from $24 at Mizuho

2026-05-07T16:02:55.000Z - 3 months ago

Adma Biologics price target lowered to $20 from $24 at Mizuho

ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors

May 7, 2026, 9:16 AM EDT - 3 months ago

ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors

Adma Biologics price target lowered to $18 from $21 at Canaccord

2026-05-07T10:48:12.000Z - 3 months ago

Adma Biologics price target lowered to $18 from $21 at Canaccord

Adma Biologics reports Q1 EPS 19c, consensus 20c

2026-05-07T00:37:49.000Z - 3 months ago

Adma Biologics reports Q1 EPS 19c, consensus 20c

Adma Biologics sees FY26 revenue $530M-$560M, consensus $629.1M

2026-05-07T00:36:02.000Z - 3 months ago

Adma Biologics sees FY26 revenue $530M-$560M, consensus $629.1M

ADMA Biologics Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

ADMA Biologics Earnings Call Transcript: Q1 2026

ADMA Biologics Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

ADMA Biologics Earnings release: Q1 2026

ADMA Biologics Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

ADMA Biologics Quarterly report: Q1 2026

ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update

May 6, 2026, 4:05 PM EDT - 3 months ago

ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update

$ADMA Shareholder News: ADMA Biologics 29% Stock Drop Leads to Securities Fraud Investigation – BFA Law Encourages Investors with Losses to Act

May 6, 2026, 6:41 AM EDT - 3 months ago

$ADMA Shareholder News: ADMA Biologics 29% Stock Drop Leads to Securities Fraud Investigation – BFA Law Encourages Investors with Losses to Act

Adma Biologics announces FDA approval for Asceniv sBLA

2026-05-04T11:31:54.000Z - 3 months ago

Adma Biologics announces FDA approval for Asceniv sBLA

ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older

May 4, 2026, 7:00 AM EDT - 3 months ago

ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older

Investor Notice: ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending Investigation

May 1, 2026, 6:16 AM EDT - 3 months ago

Investor Notice: ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending Investigation

ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 29, 2026, 7:00 AM EDT - 3 months ago

ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026

$ADMA Fraud: ADMA Biologics Channel Stuffing Claims Trigger Securities Investigation – Investors Alerted to Contact BFA Law

Apr 29, 2026, 6:41 AM EDT - 3 months ago

$ADMA Fraud: ADMA Biologics Channel Stuffing Claims Trigger Securities Investigation – Investors Alerted to Contact BFA Law

ADMA Stock: ADMA Biologics Securities Fraud Investigation is Ongoing – Investors with Losses Urged to Contact BFA Law

Apr 27, 2026, 6:38 AM EDT - 3 months ago

ADMA Stock: ADMA Biologics Securities Fraud Investigation is Ongoing – Investors with Losses Urged to Contact BFA Law

$ADMA Investigation: BFA Law Notifies ADMA Biologics Investors that Lost Money after 29% Stock Drop of Ongoing Securities Fraud Investigation

Apr 22, 2026, 6:05 AM EDT - 3 months ago

$ADMA Investigation: BFA Law Notifies ADMA Biologics Investors that Lost Money after 29% Stock Drop of Ongoing Securities Fraud Investigation

Adma Biologics initiated with a Buy at Canaccord

2026-04-21T09:25:41.000Z - 3 months ago

Adma Biologics initiated with a Buy at Canaccord

Adma Biologics initiated with a Buy at Canaccord

2026-04-20T20:45:12.000Z - 3 months ago

Adma Biologics initiated with a Buy at Canaccord

ADMA Securities News: ADMA Biologics Hit with Securities Fraud Investigation after Channel Stuffing Claims Trigger 29% Stock Drop – Investors Urged to Contact BFA Law

Apr 20, 2026, 6:33 AM EDT - 3 months ago

ADMA Securities News: ADMA Biologics Hit with Securities Fraud Investigation after Channel Stuffing Claims Trigger 29% Stock Drop – Investors Urged to Contact BFA Law

ADMA Biologics Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 3 months ago

ADMA Biologics Proxy statement: Proxy filing

ADMA Biologics Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 3 months ago

ADMA Biologics Proxy statement: Proxy filing

Adma Biologics price target lowered to $24 from $30 at Mizuho

2026-04-13T14:43:12.000Z - 4 months ago

Adma Biologics price target lowered to $24 from $30 at Mizuho

Adma Biologics responds to short seller report by Culper Research

2026-03-27T11:42:03.000Z - 4 months ago

Adma Biologics responds to short seller report by Culper Research

Adma Biologics falls -15.9%

2026-03-26T16:06:09.000Z - 4 months ago

Adma Biologics falls -15.9%

Adma Biologics falls -19.9%

2026-03-26T14:07:02.000Z - 4 months ago

Adma Biologics falls -19.9%

Cantor downgrades Adma Biologics on lack of clarity post short report

2026-03-26T08:50:09.000Z - 4 months ago

Cantor downgrades Adma Biologics on lack of clarity post short report

Adma Biologics says Culper report contains ‘inaccurate statements’

2026-03-25T23:25:28.000Z - 4 months ago

Adma Biologics says Culper report contains ‘inaccurate statements’

Adma Biologics downgraded to Neutral from Overweight at Cantor Fitzgerald

2026-03-25T23:25:22.000Z - 4 months ago

Adma Biologics downgraded to Neutral from Overweight at Cantor Fitzgerald

Adma Biologics falls -12.6%

2026-03-25T16:06:37.000Z - 4 months ago

Adma Biologics falls -12.6%

justusfied
justusfied Aug. 3 at 4:24 PM
$ADMA after the Culper crap, I stopped watching this stock and just acknowledged I’ll be holding large bags for quite some time. My timeline was. $30 by 2030. Has anything fundamentally changed that makes that number look unattainable now?
0 · Reply
USMAgrad
USMAgrad Aug. 3 at 3:14 PM
$ADMA Nice lil bounce back after that $8.50-ish dip!
0 · Reply
apc62657
apc62657 Aug. 2 at 1:43 PM
$ADMA Mckesson revenue should kick in strongly this quarter. That coupled with normalization of Bivigam would make for a strong quarter
1 · Reply
StockBraker
StockBraker Aug. 1 at 1:40 PM
$ADMA Wednesday - 4:05PM EST - I'm going to either be drinking or drinking.
2 · Reply
buylocellhi
buylocellhi Jul. 30 at 5:54 PM
$ADMA there is only 1 golden rule to trading with the computers and actually gives the trader a chance at being successful but looking at the board, I don’t think anybody has figured it out yet… au revoir
0 · Reply
StockBraker
StockBraker Jul. 30 at 2:51 PM
$ADMA Adding more.
0 · Reply
tilance
tilance Jul. 30 at 2:38 PM
$ADMA opened a position here today.,.
0 · Reply
Patastic
Patastic Jul. 30 at 12:57 PM
$ADMA Welp. Days are getting shorter. I’m back in Baby! Time to fly. Let’s go!
0 · Reply
StockBraker
StockBraker Jul. 29 at 8:25 PM
$ADMA https://ir.admabiologics.com/news-releases/news-release-details/adma-biologics-report-second-quarter-2026-financial-results
0 · Reply
Merlintrader
Merlintrader Jul. 29 at 4:47 PM
$ADMA ADMA Biologics (Nasdaq: $ADMA): The Full Updated Deep Dive Into ASCENIV, Q1 2026, IVIG Market Pressure, Margin Expansion and the Revenue-Quality Test https://www.merlintrader.com/adma-biologics-stock-hub/
0 · Reply
StockBraker
StockBraker Jul. 29 at 10:38 AM
$ADMA Kaitlin's (COO) Form 4 filed yesterday for disposition of 3,177 shares to satisfy RSU tax withholding. Kaitlin continues to hold 443K shares following this transaction ($3.7M) and would like to see this 3x. 😉I concur and believe we all would too. https://ir.admabiologics.com/static-files/e0990d86-ae73-42bf-b612-009d932546f3 For email updates - https://ir.admabiologics.com/press-releases/email-alerts
1 · Reply
StockBraker
StockBraker Jul. 28 at 12:53 PM
$ADMA Generally they announce 1 week prior so I expect a PR tomorrow at the earliest. I was wrong about the stock moving up to $13 this month, but still believe we'll see some relief after a solid ER. It's unfortunate that Culper and the ambulance chasers have been a major drag on the stock. ADMA remains a part of the S&P Smallcap 600, which is encouraging. Next rebalance should be announced early September and become effective prior to market open on the third Monday of September. "ADMA Biologics is estimated* to report its second quarter 2026 (Q2 2026) financial results on August 5, 2026"
0 · Reply
USMAgrad
USMAgrad Jul. 27 at 7:49 PM
$ADMA Welp THIS was a nice little move today. Would be lovely to see the momentaum carry it over the $9 mark tomorrow
0 · Reply
Meli12
Meli12 Jul. 27 at 7:33 AM
$ADMA I have been watching for a minute. I’m interested. I have a real question. What are the long hold‘s, thoughts about the lawsuit?
3 · Reply
Bur11
Bur11 Jul. 26 at 8:48 PM
$ADMA Short sellers better take a look at ADMA history of revenue growth and share prices. ADMA Biologics didn't get here by accident. History will mostly likely repeat because they have the technology.
1 · Reply
oldhockeyplayerwithteeth
oldhockeyplayerwithteeth Jul. 25 at 2:10 PM
$ADMA No Buyout at these prices and no stock purchase by Mgt. Only life Preserver is SG-001 in a couple of years. Wonder if Tutes were giving Grossman an earful after last bungled earnings and delayed guidance.
0 · Reply
Orange99
Orange99 Jul. 24 at 10:21 PM
$ADMA Another quarter where the stock just dribbles down as we get closer to earnings . I can see $7 handles next week maybe even $6 handles by earnings. No insider buying at what we thought was a bargain price . Thats a red flag. Short position is up. Maybe a sest up for another disappointing quarter? If so CEO Grossman on an even shorter leash .
1 · Reply
Orange99
Orange99 Jul. 24 at 10:09 PM
$ADMA This is a very disorganized company and it starts at the top with their CEO. You’d think when you pick up a new sell side analyst from Raymond JAmes in June 2026 with an outperform rating and a $21 price target they would include this on their IR website with other analysts who follow the company but no they didn’t. They‘re Investor Relations function is outsourced. when you call you get a prompt for either to leave a message and we’ll call you back or press the extension of the person you want to speak to. We don’t who that is. No return call either. It’s simply shareholder negligence. Just another example of how they dropped the ball like they did back in March with the sales fiasco with Bivigam. CFO was asleep at the wheel . You have 60 day give of take order book and that shouldn’t happen . Let’s hope for changes . It will only start with the activist shareholders .
0 · Reply
Rainman010
Rainman010 Jul. 24 at 8:20 PM
$ADMA keep buying Grossman, like your job depends on
0 · Reply
DarthWallstreet
DarthWallstreet Jul. 24 at 6:06 PM
$ADMA Looks like back to 7’s, maybe 6’s if market keeps tanking. “Best time to buy is when there’s blood on the streets, even if the blood is your own.” Lord Rothschild
1 · Reply
ExploringTrades
ExploringTrades Jul. 23 at 10:49 PM
$ADMA $ELPW New filings
0 · Reply
LongOrShortToMakeMoney
LongOrShortToMakeMoney Jul. 23 at 9:18 PM
$ADMA sad investment
0 · Reply